2018

Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics.…

The Tyro3, Axl, and Mertk (abbreviated TAMs) family of receptor tyrosine kinases are implicated in a wide-spectrum of human cancers, in which TAM over-expression is…

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus'​ lead candidate,…

Orexia Limited develops novel therapies based on positive modulators of the G protein-coupled receptors Orexin OX1 and OX2 for neurological diseases.

Drawing upon more than 60 years of combined experience in research in the fields of aging, regenerative medicine, combinatorial chemistry, and drug discovery Rubedo pursued…

Perception Therapeutics is developing curative gene therapies for genetic blindness.

Proneurotech is a biopharmaceutical company backed by The Column Group focused on discovering and developing neuroprotective drugs that prevent axon loss after acute injury or…

RemAb is developing a pipeline with different indications. his most advanced program aims to provide immediate protection to patients admitted to Intensive Care Units (ICU) without…

Samsara Therapeutics Inc. is a platform company engaged in the discovery and development of compounds that address the primary molecular causes of disease initiation and…

Repair Biotechnologies is a biotechnology company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the…